Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drug.

IF 3 3区医学 Q2 PHARMACOLOGY & PHARMACY

British journal of clinical pharmacology Pub Date : 2025-10-09 DOI:10.1111/bcp.70313

Dominique G Stuijt, Victor M Cnossen, Amira F Y S M Osman, Teun van Gelder, Sandra M Arend

引用次数: 0

Abstract

Herpes simplex virus (HSV) may cause recurring oral or genital ulcers. We report a series of patients nonresponsive to suppressive valacyclovir therapy, explained by subtherapeutic acyclovir plasma levels. After a dose increase, or in some patients only after concomitant prescription of cimetidine, adequate levels were reached associated with significant clinical improvement.

查看原文本刊更多论文

使用西咪替丁提高复发性单纯疱疹病毒感染无效抑制治疗患者全身阿昔洛韦浓度：一种旧药物的新目的。

单纯疱疹病毒（HSV）可引起口腔或生殖器溃疡复发。我们报告了一系列对抑制性伐昔洛韦治疗无反应的患者，解释了亚治疗性伐昔洛韦血浆水平。在剂量增加后，或在一些患者仅在同时处方西咪替丁后，达到足够的水平与显著的临床改善相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British journal of clinical pharmacology 医学-药学

CiteScore

6.30

自引率

8.80%

发文量

419

审稿时长

1 months

期刊介绍： Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.